Decreased expression of brain beta-dystroglycan in Duchenne muscular dystrophy but not in the mdx animal model.
Abnormalities in the muscle dystrophin-glycoprotein complex are implicated in the molecular pathogenesis of various neuromuscular disorders. Weakening of the trans-sarcolemmal linkage between the actin membrane-cytoskeleton and the extracellular matrix appears to trigger destabilization of the muscle cell periphery. In addition to muscular weakness, one-third of patients suffering from Duchenne muscular dystrophy exhibit mental retardation. Since little is known about the pathophysiology of brain abnormalities in these patients, we investigated the fate of the most abundant dystrophin-associated protein, beta-dystroglycan, in the central nervous system. It was found to be present throughout all normal brain regions studied. In contrast, this glycoprotein was greatly reduced in brain microsomes derived from Duchenne specimens, while it is of normal abundance in the brain from the dystrophic animal model mdx. Deficiency in brain beta-dystroglycan might render nervous tissue more susceptible to cellular disturbances and this may result in cognitive impairment in some Duchenne patients.
Department of Pharmacology, University College Dublin, Ireland.
D M
DM
Finn
K G
KG
Culligan
K
K
Ohlendieck
D000818:Animals; D001921:Brain / Q000378:metabolism*; D003598:Cytoskeletal Proteins / Q000096:biosynthesis*; D049030:Dystroglycans; D008562:Membrane Glycoproteins / Q000096:biosynthesis*; D051379:Mice; D018101:Mice, Inbred mdx; D009136:Muscular Dystrophies / Q000378:metabolism*; D011817:Rabbits
D003598:Cytoskeletal Proteins; D008562:Membrane Glycoproteins; D049030:Dystroglycans